American Century Companies’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
American Century Companies's FLNA Position: Q1 2026 in Review
American Century Companies held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 53,367 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.
American Century Companies first reported a position in FLNA in Q3 2025 and has held it in 3 quarters since. The position peaked at $113K in Q3 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- American Century Companies held 53,367 shares of Filana Therapeutics worth $90.2K as of Q1 2026.
- American Century Companies left its Filana Therapeutics share count unchanged in Q1 2026.
- Filana Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2784 holding.
- American Century Companies first reported a position in Filana Therapeutics in Q3 2025 and has held it in 3 quarters since.
- American Century Companies's Filana Therapeutics position peaked at $113K in Q3 2025.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.